These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 30656214)

  • 1. Infectious Disease Transmission in Solid Organ Transplantation: Donor Evaluation, Recipient Risk, and Outcomes of Transmission.
    White SL; Rawlinson W; Boan P; Sheppeard V; Wong G; Waller K; Opdam H; Kaldor J; Fink M; Verran D; Webster A; Wyburn K; Grayson L; Glanville A; Cross N; Irish A; Coates T; Griffin A; Snell G; Alexander SI; Campbell S; Chadban S; Macdonald P; Manley P; Mehakovic E; Ramachandran V; Mitchell A; Ison M
    Transplant Direct; 2019 Jan; 5(1):e416. PubMed ID: 30656214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New blood-borne virus infections among organ transplant recipients: An Australian data-linked cohort study examining donor transmissions and other HIV, hepatitis C and hepatitis B notifications, 2000-2015.
    Waller KMJ; De La Mata NL; Hedley JA; Rosales BM; O'Leary MJ; Cavazzoni E; Ramachandran V; Rawlinson WD; Kelly PJ; Wyburn KR; Webster AC
    Transpl Infect Dis; 2020 Dec; 22(6):e13437. PubMed ID: 32767859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.
    Irwin L; Kotton CN; Elias N; Palafox J; Basler D; Shao SH; Lester W; Zhang X; Kimball B; Trencher C; Fishman JA
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28994164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Biovigilance in Organ Donation (SAFEBOD): Protocol for a Population-Based Cohort Study.
    Rosales B; Hedley J; De La Mata N; Vajdic CM; Kelly P; Wyburn K; Webster AC;
    JMIR Res Protoc; 2020 Oct; 9(10):e18282. PubMed ID: 33104005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the OPTN transmissible diseases policy and US PHS increased risk donor guidelines on living donor candidates.
    Hays R; Gordon EJ; Ison MG; LaPointe Rudow D
    Am J Transplant; 2019 Dec; 19(12):3233-3239. PubMed ID: 31338956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020.
    Jones JM; Kracalik I; Levi ME; Bowman JS; Berger JJ; Bixler D; Buchacz K; Moorman A; Brooks JT; Basavaraju SV
    MMWR Recomm Rep; 2020 Jun; 69(4):1-16. PubMed ID: 32584804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
    Shaikh OS; Rogal S; Malik A; Sharma V; Cacciarelli T
    Exp Clin Transplant; 2020 Oct; 18(5):605-611. PubMed ID: 31324136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of Hepatitis C Virus From Organ Donors Despite Nucleic Acid Test Screening.
    Suryaprasad A; Basavaraju SV; Hocevar SN; Theodoropoulos N; Zuckerman RA; Hayden T; Forbi JC; Pegues D; Levine M; Martin SI; Kuehnert MJ; Blumberg EA;
    Am J Transplant; 2015 Jul; 15(7):1827-35. PubMed ID: 25943299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation.
    Seem DL; Lee I; Umscheid CA; Kuehnert MJ
    Am J Transplant; 2013 Aug; 13(8):1953-62. PubMed ID: 23890284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raccoon rabies virus variant transmission through solid organ transplantation.
    Vora NM; Basavaraju SV; Feldman KA; Paddock CD; Orciari L; Gitterman S; Griese S; Wallace RM; Said M; Blau DM; Selvaggi G; Velasco-Villa A; Ritter J; Yager P; Kresch A; Niezgoda M; Blanton J; Stosor V; Falta EM; Lyon GM; Zembower T; Kuzmina N; Rohatgi PK; Recuenco S; Zaki S; Damon I; Franka R; Kuehnert MJ;
    JAMA; 2013 Jul; 310(4):398-407. PubMed ID: 23917290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management.
    Huprikar S; Danziger-Isakov L; Ahn J; Naugler S; Blumberg E; Avery RK; Koval C; Lease ED; Pillai A; Doucette KE; Levitsky J; Morris MI; Lu K; McDermott JK; Mone T; Orlowski JP; Dadhania DM; Abbott K; Horslen S; Laskin BL; Mougdil A; Venkat VL; Korenblat K; Kumar V; Grossi P; Bloom RD; Brown K; Kotton CN; Kumar D
    Am J Transplant; 2015 May; 15(5):1162-72. PubMed ID: 25707744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatrics and donor-derived disease transmission: The US OPTN experience.
    Green M; Covington S; Taranto S; Michaels MG; Wolfe C; Kaul DR
    Pediatr Transplant; 2018 Feb; 22(1):. PubMed ID: 29341396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-Derived Infections: Monitoring of Posttransplant Infections and Safety Lessons From the Opioid Epidemic.
    Fishman JA; Irwin L
    Exp Clin Transplant; 2022 Aug; 20(Suppl 4):20-23. PubMed ID: 36018015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual risk of infection with blood-borne viruses in potential organ donors at increased risk of infection: systematic review and meta-analysis.
    Waller KM; De La Mata NL; Kelly PJ; Ramachandran V; Rawlinson WD; Wyburn KR; Webster AC
    Med J Aust; 2019 Nov; 211(9):414-420. PubMed ID: 31489635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ Transplants From Deceased Donors With Primary Brain Tumors and Risk of Cancer Transmission.
    Greenhall GHB; Rous BA; Robb ML; Brown C; Hardman G; Hilton RM; Neuberger JM; Dark JH; Johnson RJ; Forsythe JLR; Tomlinson LA; Callaghan CJ; Watson CJE
    JAMA Surg; 2023 May; 158(5):504-513. PubMed ID: 36947028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of disease transmission in an expanded donor population: the potential of hepatitis B virus donors.
    Zhou K; Zhou S
    Curr Opin Organ Transplant; 2020 Dec; 25(6):631-639. PubMed ID: 33027191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing Tissue Transmission of Hepatitis C Virus From Viremic Donor to Seronegative Kidney Transplant Recipients: A Case Series.
    Franco A; Gosalvez C; Gimeno A; Trigueros M; Balibrea N; Perez Contreras FJ
    Transpl Int; 2023; 36():11110. PubMed ID: 37534060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of renal transplants from Centers for Disease Control and Prevention high-risk donors with prospective recipient viral testing: a single-center experience.
    Lonze BE; Dagher NN; Liu M; Kucirka LM; Simpkins CE; Locke JE; Desai NM; Cameron AM; Montgomery RA; Segev DL; Singer AL
    Arch Surg; 2011 Nov; 146(11):1261-6. PubMed ID: 22106317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV-infected solid organ donors, direct-acting antivirals and the current challenges.
    Fabrizi F; Cerutti R; Silva M
    Expert Rev Clin Pharmacol; 2020 Jan; 13(1):7-14. PubMed ID: 31786966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.